Vaginal Diseases: Clinical Trials

682 trials for Vaginal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

414 completed, 101 unknown, 63 recruiting, 31 terminated. 224 Not applicable, 117 Phase 3, 112 Phase 2, 84 Phase 1, 56 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable224Completed 129, Unknown 36, Recruiting 24, Not yet recruiting 10, Terminated 8, Withdrawn 8, Active not recruiting 7, Enrolling by invitation 1, Suspended 1
Phase 3117Completed 80, Unknown 21, Terminated 5, Recruiting 4, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2
Phase 2112Completed 61, Unknown 15, Recruiting 13, Withdrawn 7, Terminated 6, Not yet recruiting 5, Active not recruiting 4, Suspended 1
Phase 184Completed 48, Unknown 11, Terminated 7, Recruiting 6, Active not recruiting 4, Withdrawn 4, Not yet recruiting 3, Suspended 1
Phase 456Completed 37, Unknown 9, Not yet recruiting 4, Terminated 4, Recruiting 2
Early Phase 113Completed 8, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1

Follow Vaginal Diseases: new trials by email Literature Review of Vaginal Diseases trials Research Report on Vaginal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment
metronidazole (MTZ)+ LCFA-01 placebo + LC103 placebo, metronidazole (MTZ)+ LCFA-01 + LC103 placebo, metronidazole (MTZ)+ LC103 + LCFA-01 placebo - Bacterial Vaginosis
Phase 1Not yet recruitingMassachusetts General Hospital2802027-02-032026-10-15
Prevention of Vaginal Cuff Infection After Hysterectomy by Addition of Vaginal Clindamycin
Clindamycin Vaginal Gel - Surgical Site Infection, Vaginal Cuff Cellulitis
Enrolling by invitationBaylor Research Institute9002026-12-012026-10-22
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Effect of Multimodal Physical Therapy on Vaginismus Secondary to Chronic Constipation
Conventional physiotherapy, Multimodal physical therapy program - Vaginismus, Chronic Constipation
Not applicableNot yet recruitingCairo University402026-11-012026-11-09
WST03 Capsule Combined With Metronidazole for Bacterial Vaginosis
High-dose WST03 Vaginal Capsule Metronidazole, Low-dose WST03 Vaginal Capsule Metronidazole, Placebo Vaginal Capsule Metronidazole - Bacterial Vaginosis (BV)
Phase 2Not yet recruitingSPH Sine Pharmaceutical Laboratories Co., Ltd.1502026-10-202026-10-22
Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions
Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer
RecruitingAffidea Nu-med Center of Oncological DIagnostics and Therapy5002026-10-062026-10-23
AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth
Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis
Phase 3Not yet recruitingAssistance Publique Hopitaux De Marseille17942026-10-012026-08-27
Photobiomodulation With Blue LED in Recurrent Bacterial Vaginosis
Metronidazole, Blue Light-Emitting Diode (LED) - Bacterial Vaginosis
Not applicableNot yet recruitingPatricia Lordelo402026-09-302026-09-23
Vagina-View Safety and Imaging Feasibility
Vagina-View (VV) device - Vaginal Cancer
Not applicableRecruitingUniversity Health Network, Toronto102026-09-152026-09-17
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingCity of Hope Medical Center1262026-09-092026-10-16
Implementing Virtual Reality Exposure Therapy for Vaginismus: From Efficacy to Clinical Integration (VIVID 3)
Implementation of Virtual Reality Exposure - Vaginismus, Difficulties With Vaginal Penetration
Not applicableNot yet recruitingUniversity of British Columbia1672026-09-012026-08-05
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Vaginal estradiol tablets, Vaginal moisturizer - Menopausal Complaints, Vaginal Atrophy
Phase 4Not yet recruitingAlbert Einstein College of Medicine622026-09-012026-07-28
MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH
Vaginal Microbiome Transplantation (VMT), oral metronidazole, Sterile saline solution - Recurrent Bacterial Vaginosis (BV)
Phase 2Not yet recruitingDouglas Kwon752026-09-012026-05-18
Measuring Pelvic Floor Muscle Fitness Before and After Treatment
Near Infrared Imaging - Myofacial Pain, Pelvic Pain
Not applicableNot yet recruitingUniversity of California, Los Angeles1202026-09-012026-05-26
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)
GenSci142 capsule, clindamycin phosphate vaginal cream - Randomized, Open-label
Phase 1RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.422026-08-152026-10-15
Improving Maternal and Child Health Through Point-of-care STI Testing
Point-of-care STI tests, Standard of care STI testing - Treponema Pallidum Infection, Chlamydia Trachomatis Infection
Not applicableRecruitingEmory University7562026-08-112026-08-19
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Blue LED Photobiomodulation - Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis
Not applicableNot yet recruitingPatricia Lordelo1502026-07-302026-07-13
F-GYN for Vaginal Dryness and Vulvovaginal Atrophy
F-GYN Non-Crosslinked Hyaluronic Acid Injectable Gel, Standard Non-Hormonal Symptomatic Care - Atrophic Vaginitis, Atrophic Vulvovaginitis
Not applicableRecruitingBiovico Sp. z o.o.1302026-07-242026-10-01
Immersive Visual Modulation and Ambient Music Therapy During Transvaginal Ultrasonography in Women With Vaginismus
Standard Care, Immersive Visual Modulation (IVM), Ambient Music Therapy (AMT) - Vaginismus
Not applicableEnrolling by invitationDemet Mutlu902026-07-162026-09-23
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Not applicableWithdrawnCity of Hope Medical Center2026-07-162026-02-04

Showing 20 of 682. Sign in to see all of them.

Narrower conditions

Vaginosis, Bacterial (235)  ·  Vaginal Neoplasms (158)  ·  Uterine Cervical Neoplasms (141)  ·  Vulvar Neoplasms (115)  ·  Candidiasis, Vulvovaginal (107)  ·  Vaginitis (98)  ·  Endometrial Neoplasms (73)  ·  Ovarian Neoplasms (58)  ·  Atrophic Vaginitis (44)  ·  Fallopian Tube Neoplasms (37)  ·  Anus Neoplasms (33)  ·  Uterine Neoplasms (29)  ·  Vaginismus (29)  ·  Carcinoma, Ovarian Epithelial (28)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (682)  ·  Genital Diseases (682)  ·  Female Urogenital Diseases (679)  ·  Urogenital Diseases (678)  ·  Genital Diseases, Female (677)  ·  Infections (381)  ·  Vaginitis (337)  ·  Bacterial Infections and Mycoses (329)  ·  Bacterial Infections (237)  ·  Vulvar Diseases (231)  ·  Neoplasms by Site (163)  ·  Urogenital Neoplasms (159)  ·  Uterine Diseases (158)  ·  Genital Neoplasms, Female (152)

Interventions

Metronidazole (53)  ·  Fluconazole (23)  ·  Clotrimazole (12)  ·  Clindamycin (11)  ·  Radiotherapy (11)  ·  Probiotics (10)  ·  Brachytherapy (8)  ·  Dehydroepiandrosterone (8)  ·  Estradiol (8)  ·  ibrexafungerp (8)  ·  Surveys and Questionnaires (7)  ·  Magnetic Resonance Spectroscopy (6)  ·  Ospemifene (6)  ·  VT-1161 (6)  ·  secnidazole (6)

Sponsors

M.D. Anderson Cancer Center (11)  ·  Merck Sharp & Dohme LLC (11)  ·  National Cancer Institute (NCI) (10)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (9)  ·  Gedea Biotech AB (8)  ·  Scynexis, Inc. (8)  ·  University of Pittsburgh (8)  ·  Assiut University (7)  ·  Peking University Shenzhen Hospital (7)  ·  Shanghai Bovax Biotechnology Co., Ltd. (7)  ·  EndoCeutics Inc. (6)  ·  Memorial Sloan Kettering Cancer Center (6)  ·  Ohio State University Comprehensive Cancer Center (6)  ·  Shionogi (6)  ·  Starpharma Pty Ltd (6)

Countries

United States (258)  ·  China (46)  ·  Canada (30)  ·  France (25)  ·  United Kingdom (24)  ·  Italy (21)  ·  Israel (17)  ·  Spain (17)  ·  Brazil (15)  ·  Egypt (15)  ·  Sweden (14)  ·  Germany (13)  ·  Belgium (11)  ·  India (11)  ·  Turkey (Türkiye) (11)

Top investigators

Shangrong Fan, M.D. (5)  ·  Anne Reb (3)  ·  Clare Shaw, Phd (3)  ·  David Angulo, MD (3)  ·  David F Archer, MD (3)  ·  Jeremy Paull, PhD (3)  ·  Robert J Borgman, Ph.D. (3)  ·  Sharon L Hillier, PhD (3)  ·  Alena Jandourek, MD (2)  ·  Allison M Quick, MD (2)  ·  Andrea R Thurman, MD (2)

Results publications

PMID 26972555, PMID 36396498, PMID 25968836, PMID 27422279, PMID 40709601, PMID 19949018, PMID 21854593, PMID 22002018, PMID 23985562, PMID 25734980, PMID 26291918, PMID 26517756, PMID 26597311, PMID 26634942, PMID 26731686, PMID 29211620, PMID 29269325, PMID 29767739, PMID 33207004, PMID 33326342, PMID 36255448, PMID 37431855, PMID 37619252, PMID 38319878, PMID 40970688, PMID 10028110, PMID 10371477, PMID 11166145, PMID 11230468, PMID 11425832, PMID 11463927, PMID 11576584, PMID 12015520, PMID 12048413, PMID 12625969, PMID 12762087, PMID 12861145, PMID 12954522, PMID 14672465, PMID 15008773, PMID 15028938, PMID 1504154, PMID 15089868, PMID 15118630, PMID 15291998, PMID 1535108, PMID 15458898, PMID 15902186, PMID 16145097, PMID 16303068

NIH funding

2023 (3), P30CA033572 (3), P30CA043703 (3), 2009 (2), 2014 (2), 2017 (2), R21CA293326 (2), U01CA062502 (2), U10CA180868 (2), 2008 (1), 2019 (1), 2025 (1), K23AG062400 (1), KL2RR025754 (1), P30AI027757 (1)